Mutations in MLH1, MSH2, MSH6, PMS2, and other MMR related genes, promoter methylation and epigenetic changes resulted in the loss of MMR protein, which eventually led to the presence of MSI‐H in CRC. This evidence concerns the gene PMS2 and colorectal carcinoma.